Objective: We aimed to detect possible cardiac pathologies early by cardiologically evaluating patients newly diagnosed with chronic obstructive pulmonary disease (COPD). Materials and methods: The study included 69 newly diagnosed COPD patients who came to our outpatient clinic and 39 individuals who had smoked for at least 20 years. Both groups were evaluated in chest diseases and grouped according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and then evaluated in the cardiology outpatient clinic. Results: Of the COPD patients included in the study, 49 (71.01%) were male, and 20 (29.99%) were female. The COPD patient group was divided into three groups based on the 2023 GOLD strategy report. There were a total of 38 (35.2%) patients in the GOLD-A group, 28 (73.7%) male and 10 (26.3%) female. The right branch block was seen in 15 (13.9%) of all participants. A total of 14 of them were in the COPD group, and one of them was in the control group. Of the COPD patients with right branch block, 10 (26.3%) were in the GOLD-A group, three (12.5%) were in the GOLD-B group, and one (14.3%) was in the GOLD-E group. Diastolic dysfunction was seen in 38 (55.1%) COPD patients and 14 (35.9%) control groups. Of the patients with COPD with diastolic dysfunction, 22 (57.9%) were in the GOLD-A group, and 20 (55.3%) of them were in grade 1. Mitral valve disease was detected in 19 (27.5%) of the patients with COPD, tricuspid valve disease in 18 (26.1%), and aortic valve disease in two (2.9%) patients. Conclusion: We have seen that a significant number of our patients have started their cardiological pathologies during the initial diagnosis. With this strategy, cardiac pathologies can be intervened early, and better results can be obtained in the management of COPD.